Bladder Cancer,Genitourinary Cancer Erdafitinib in BCG-Resistant HR NMIBC With FGFR Mutations Dec 20, 2023
Bladder Cancer,Genitourinary Cancer Real-World Use of Avelumab Maintenance in Advanced UC Patients Dec 14, 2023
Bladder Cancer,Genitourinary Cancer Erdafitinib vs. Pembrolizumab in Advanced UC With FGFR Alterations Dec 14, 2023
Genitourinary Cancer,Prostate Cancer Omega-3 MAG-EPA Supplement Impact on Prostate Cancer and Gut Microbiome Dec 12, 2023
Genitourinary Cancer,Prostate Cancer Real-World MACE and Mortality Risk in Prostate Cancer Dec 12, 2023
Genitourinary Cancer,Prostate Cancer Lutetium-177–PSMA-617 Tolerance in Prostate Cancer Men With Baseline Cytopenia Dec 12, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Post-immunotherapy Nephrectomy Safety in Advanced RCC Dec 11, 2023
